This study provides evidence that combining β3-adrenergic stimulation with PPARα activation can promote metabolic effects that stimulate energy expenditure, including UCP1-mediated thermogenesis, providing a potential therapeutic approach for the treatment of obesity. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.